Evidence map›Paper›PMID 40327534›Full record

ArticleeLife2025

Shc1 cooperates with Frs2 and Shp2 to recruit Grb2 in FGF-induced lens development.

Qian Wang, Hongge Li, Yingyu Mao, Ankur Garg, Eun Sil Park, Yihua Wu, Alyssa Chow, John Peregrin, Xin Zhang

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Qian Wang *Department of Ophthalmology, Columbia University, New York, United States.ORCID https://orcid.org/0000-0002-6166-3081
Hongge Li *Department of Ophthalmology, Columbia University, New York, United States.ORCID https://orcid.org/0000-0003-0237-3225
Yingyu Mao *Department of Ophthalmology, Columbia University, New York, United States.
Ankur GargDepartment of Ophthalmology, Columbia University, New York, United States.
Eun Sil ParkDepartment of Ophthalmology, Columbia University, New York, United States.
Yihua WuDepartment of Ophthalmology, Columbia University, New York, United States.
Alyssa ChowDepartment of Ophthalmology, Columbia University, New York, United States.
John PeregrinDepartment of Ophthalmology, Columbia University, New York, United States.
Xin ZhangDepartment of Ophthalmology, Columbia University, New York, United States.ORCID https://orcid.org/0000-0001-5555-0825

Funding

Instrumentation, Fabrication, and Design CoreP30EY019007 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Xin Zhang · 2010 to 2026
$12.9M
Signaling Mechanisms of Lens DevelopmentR01EY017061 · NEI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI ZHANG, XIN · 2006 to 2025
$9.0M
Regulation of FGF signaling in lacrimal gland developmentR01EY018868 · NEI · INDIANA UNIVERSITY INDIANAPOLIS · PI Xin Zhang · 2009 to 2026
$6.3M
PDGF signaling in lens developmentR01EY025933 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ZHANG, XIN · 2015 to 2023
$3.2M
Signaling networks and transcriptional programs in lens vesicle formationR00EY032171 · NEI · WASHINGTON UNIVERSITY · PI Qian Wang · 2025 to 2026
$498k
Signaling networks and transcriptional programs in lens vesicle formationK99EY032171 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WANG, QIAN · 2022 to 2023
$237k
NEI NIH HHS EY018868NEI NIH HHS K99 EY032171NEI NIH HHS K99EY032171NEI NIH HHS P30 EY019007NEI NIH HHS R00 EY032171NEI NIH HHS R01 EY017061NEI NIH HHS R01EY017061NEI NIH HHS R01 EY018868NEI NIH HHS R01 EY025933NEI NIH HHS R01EY025933
6 · The paper itself

Abstract

Fibroblast growth factor (FGF) signaling elicits multiple downstream pathways, most notably the Ras/MAPK cascade facilitated by the adaptor protein Grb2. However, the mechanism by which Grb2 is recruited to the FGF signaling complex remains unresolved. Here, we showed that genetic ablation of FGF signaling prevented murine lens induction by disrupting transcriptional regulation and actin cytoskeletal arrangements, which could be reproduced by deleting the juxtamembrane region of the FGF receptor and rescued by Kras activation. Conversely, mutations affecting the Frs2-binding site on the FGF receptor or the deletion of Frs2 and Shp2 primarily impact later stages of lens vesicle development involving lens fiber cell differentiation. Our study further revealed that the loss of Grb2 abolished MAPK signaling, resulting in a profound arrest of lens development. However, removing Grb2's putative Shp2 dephosphorylation site (Y209) neither produced a detectable phenotype nor impaired MAPK signaling during lens development. Furthermore, the catalytically inactive Shp2 mutation (C459S) only modestly impaired FGF signaling, whereas replacing Shp2's C-terminal phosphorylation sites (Y542/Y580) previously implicated in Grb2 binding only caused placental defects, perinatal lethality, and reduced lacrimal gland branching without impacting lens development, suggesting that Shp2 only partially mediates Grb2 recruitment. In contrast, we observed that FGF signaling is required for the phosphorylation of the Grb2-binding sites on Shc1 and the deletion of Shc1 exacerbates the lens vesicle defect caused by Frs2 and Shp2 deletion. These findings establish Shc1 as a critical collaborator with Frs2 and Shp2 in targeting Grb2 during FGF signaling.

Indexed as

Adaptor Proteins, Signal TransducingFibroblast Growth FactorsGRB2 Adaptor ProteinLens, CrystallineMembrane ProteinsProtein Tyrosine Phosphatase, Non-Receptor Type 11Src Homology 2 Domain-Containing, Transforming Protein 1AnimalsMiceSignal TransductionAdaptor Proteins, Signal TransducingFibroblast Growth FactorsFRS2alpha protein, mouseGRB2 Adaptor ProteinGrb2 protein, mouseMembrane ProteinsProtein Tyrosine Phosphatase, Non-Receptor Type 11Ptpn11 protein, mouseShc1 protein, mouseSrc Homology 2 Domain-Containing, Transforming Protein 1cell biologydevelopmental biologyFGFGrb2lens inductionMAPKmouseShcShp2

Identifiers

PMID40327534
PMCPMC12055001

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.